Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pathology and Laboratory Medicine, |
RCV001356239 | SCV001551354 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | The TMEM237 p.Gln81* variant was not identified in the literature nor was it identified in dbSNP, ClinVar, MutDB, and LOVD 3.0. The variant was identified in the Cosmic database with a FATHMM prediction score of 0.94 (pathogenic). The variant was not identified in the following control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017. The p.Gln81* variant leads to a premature stop codon at position 81 which is predicted to lead to a truncated or absent protein and loss of function. Loss of function mutations are a known disease mechanism in Joubert syndrome 14. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more pathogenic role for this variant. This variant is classified as likely pathogenic. |